Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cumberland Pharmaceuticals Inc CPIX

Healthcare
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a... see more

Recent & Breaking News (NDAQ:CPIX)

Cumberland Pharmaceuticals Reports First Quarter Financial Results

PR Newswire May 2, 2013

Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013

PR Newswire April 25, 2013

Cumberland Pharmaceuticals Reports 2012 Annual Financial Results

PR Newswire February 28, 2013

Cumberland Pharmaceuticals Licenses Caldolor® (ibuprofen) Injection To Sandor Medicaids Pvt. Ltd. For Commercialization In India

PR Newswire February 21, 2013

Caldolor® Reduces Pain And Fever In Adult Patients

PR Newswire February 19, 2013

Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013

PR Newswire February 14, 2013

Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia

PR Newswire January 29, 2013